<?xml version="1.0" encoding="UTF-8"?>
<p>SerpinG1 is the C1 complement inhibitor (inhibiting the classical pathway of the complement) but also inhibits other proteases including MASP-1 and MASP-2 in the lectin pathway. Circulating SerpinG1 protein levels increase ~2.5 folds during inflammation [
 <xref rid="ppat.1007880.ref033" ref-type="bibr">33</xref>]. Furthermore, during HIV infections, SerpinG1 mRNA levels increased in the circulating monocytes [
 <xref rid="ppat.1007880.ref024" ref-type="bibr">24</xref>]. The lectin pathway has been implicated as causing the tissue damage during alphaviral arthritis caused by the Ross River virus [
 <xref rid="ppat.1007880.ref023" ref-type="bibr">23</xref>], and SerpinG1 upregulation may act to limit such damage [
 <xref rid="ppat.1007880.ref034" ref-type="bibr">34</xref>].
</p>
